Patents/Assignees

Cantargia AB

4 patents in portfolio

US12398213utility2025
Methods of Treating IL1RAP Associated Cancers with Anti Human Interleukin-1 Receptor Accessory Protein (IL1 RAP) Antibodies
0 cites
US12209131utility2025
Anti-il1rap Antibody Compositions
0 cites
US12043666utility2024
Anti-il1rap Antibody
0 cites
US11773174utility2023
Anti-il1rap Antibodies and Their Use for Treating Humans
0 cites